About

Markus Kufeld is a radiation oncologist whose research has profoundly shaped the clinical application of robotic radiosurgery, particularly through the use of the CyberKnife system. His work spans a remarkably broad range of tumor sites, including spinal lesions, brain metastases, liver tumors, prostate cancer bone metastases, renal cell carcinoma, and cervical cancer, establishing him as a versatile pioneer in image-guided stereotactic treatment. Kufeld's most influential contribution — a 2011 study on robotic radiosurgery for prostate cancer bone metastases, now cited over 110 times — demonstrated both the safety and feasibility of this minimally invasive approach for patients with limited metastatic disease. His investigations into fiducial-free spinal radiosurgery helped validate frameless tracking techniques, improving patient comfort without sacrificing precision. Notably, his work on brachytherapy-emulating robotic radiosurgery offered a compelling alternative for cervical cancer patients unsuitable for conventional brachytherapy. Across more than a decade of research, Kufeld has consistently pushed the boundaries of noninvasive cancer treatment, providing clinicians with evidence-based guidance for treating challenging and recurrent tumors with high accuracy and acceptable toxicity profiles.

Research Focus

Key Achievements

13
H-Index
27
Papers
590
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer
110 citations · 2011
📈 Most Prolific Year: 2021 (6 Papers)
🤝 Key Collaborators: 78
🏛 Institutions: Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, European Patent Organisation, European X-Ray Free-Electron Laser

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago